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2
umn comprising an active layer capable of Separating the
analyte from the Sample in the millisecond time domain, and
an inert layer.
In yet a further aspect is provided a method for Separating
an analyte from a Sample in the millisecond time domain, the
method comprising applying the Sample to the microcolumn

LOADING MICROCOLUMS FOR THE
SEPARATION OF ANALYTES FROMA
SAMPLE IN THE MILLISECOND TIME
SCALE
FIELD OF THE INVENTION

described herein.

The current invention is generally directed toward a
microcolumn and a method of loading a microcolumn. The
microcolumn produced by the method of the invention is
capable of Separating an analyte from a Sample in the
millisecond time Scale by using Small column volumes that
can tolerate medium to high flow rates.
BACKGROUND OF THE INVENTION

BRIEF DESCRIPTION OF THE DRAWINGS

15

One area of continuing interest in the field of analytical
chemistry is the development of Separation techniques that
achieve extraction of an analyte from a Sample in the
millisecond time domain. The ability to rapidly and accu
rately Separate analytes from a Sample has a number of
important applications in the health, pharmaceutical,

porosity of 0.80 within the column (i.e., 80% of the column
Volume is occupied by the mobile phase). Using a column

clinical, research and environmental fields. One Such

application, for example, is the ability to rapidly extract the
biologically active form of a drug, hormone, or toxin from
a biological Sample. This is of particular interest in clinical
chemistry and pharmaceutical Science as a means for con
trolling and Studying the effect of drugs and/or hormones
within the body.
Techniques such as microbore HPLC and capillary HPLC
have attempted to decrease Separation times and increase
Separation efficiency by decreasing column diameter with a
corresponding increase in column length. The Small column

25
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ration in the millisecond time domain.

50

mobile phase to Stagnant mobile phase within the
Support. The Second-order rate constant k describes
the actual adsorption of the analyte to the Stationary
phase. A reverse first-order rate constant for analyte

desorption could also be included in this model (k);

however, this was not necessary in this current Study
Since analyte binding to the column was essentially
irreversible on the time Scale of the extraction Studies.

55

FIG. 6 depicts extraction of fluorescein using an anti
fluorescein immunoaffinity Support. Microcolumns
varying in lengths from 124 um to 620 um were used
for this Study along with various flow rates to adjust the

60

FIG. 7 depicts extraction of hemoglobin using a reversed
phase chromatographic Support. Microcolumns varying in
lengths from 62 um to 620 um were used for this Study along
with various flow rates to adjust the column residence times.
FIG. 8 depicts a competitive binding immunoassay for
albumin performed on a column that contained anti-albumin
antibodies as the Stationary phase. The column was prepared
and Sample injections were performed as described in the

SUMMARY OF THE INVENTION

Among the Several aspects of the invention therefore, is
provided a method of loading a microcolumn comprising an
active layer and an inert layer, the active layer being capable
of Separating an analyte from a Sample, the method com
prising introducing the active layer into the microcolumn
Such that the active layer is capable of Separating the analyte
from the Sample within the millisecond time domain, and
introducing the inert layer.
Another aspect of the invention is provided a microcol
umn for Separating an analyte from a Sample, the microcol

injections which were used to apply to fixed amount of an
immobilized hemoglobin Support to a 2.1 mm IDX620 um
microcolumn. These results represent the average result of
triplicate analyses.
FIG. 4 depicts pressure versus flow rate for columns
packed with Nucleosil Si-10000 or Nucleosil Si-300 Ol
Supports. These measurements were performed at room
temperature using pH 7.0, 0.1M potassium phosphate buffer
as the mobile phase. The error bars shown about each point
represent a range of t1 SD for triplicate measurements.
FIG. 5 depicts the general Scheme used to represent
analyte extraction by microcolumns. The forward and
reverse mass transfer rate constants k and k repre

Sent movement of the analyte (A) from the flowing

millimeters to Several centimeters in diameter and Several

millimeters in length have been developed. However, like
the immunoaffinity columns previously discussed, the mem
brane Supports are not capable of Separating an analyte from
a Sample in the millisecond time domain.
Accordingly, a need exists for a column with dimensions
that are capable of achieving a high rate of Selective Sepa

with an inner diameter of 1 mm or 4 mm gives Similar results
but with the vertical position of the lines in this graph being
lowered or raised by 4-fold, respectively.
FIG. 2 depicts a typical microcolumn. This column was
packed with Nucleosil Si-300 silica and later removed from
its housing for the acquisition of this image. Immobilized
hemoglobin Silica, shown as the dark center band, was used
to visualize the Stationary phase layer after the column was
unpacked. The total length of the column shown was 1.0 cm
and the effective length of the stationary phase layer was 620
tim. The column diameter was 2.1 mm.
FIG. 3 depicts the reproducibility of stationary phase
content in a microcolumn as a function of the number of

diameter acts to decrease column volume, while the

increased column length Serves to provide more contacts
between the analyte and the Separation medium. Although
these techniques have increased separation efficiency by
obtaining narrower elution peaks, they have not resulted in
Separations in the millisecond time domain.
In another approach, Some techniques have attempted to
decrease extraction time by reducing column lengths. Many
HPLC-based immunoaffinity columns are now in the size
range of a few millimeters to a few centimeters. However,
columns with these dimensions, while Separating an analyte
from a Sample in a few Seconds, cannot achieve Separation
in the millisecond time domain. Additionally, membrane
Supports based on polymeric materials that are Several

These and other features, aspects, and advantages of the
present invention will become better understood with regard
to the following description, appended claims and accom
panying figures where:
FIG. 1 depicts change in column void time with column
length and solvent flow rate for 2 mm ID HPLC columns
packed with porous Silica. These results assume an overall

column residence times.
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text. Sample injection took place at 0 min in each plot. The
concentration of FITC-BSA in each sample was 1.6 uM. The

concentrations of non-labeled BSA were (from left-to-right)

0, 17.9 and 88.8 uM, respectively.
FIG. 9 depicts a drawing of a typical microcolumn
according to the present invention.
ABBREVIATIONS AND DEFINITION

To facilitate understanding of the invention, a number of
terms and abbreviations as used herein are defined below:

“Analyte” or “Target Analyte” are used interchangeably
herein, and Shall mean the component of the Sample to be
Separated by the active layer of the microcolumn.
“Binding Agent', as utilized herein, shall mean the agent
in the active layer capable of Separating the target analyte
from the Sample.

15

"Millisecond Time Domain or Millisecond Time Scale”

are used interchangeably herein, and shall mean any amount
of time less than one Second.

"Sandwich microcolumn', as utilized herein, Shall mean
an embodiment of the invention wherein the microcolumn

comprises a top inert layer, a bottom inert layer and an active
layer between the two inert layers.
“Sample” or “Liquid” are used interchangeably herein
and shall mean the mixture applied to the microcolumn
containing the analyte. In addition to the analyte, the Sample

25

(liquid) generally also comprises a loading buffer. Any

loading buffer may be employed to the extent that the buffer
does not interfere with the Separation process.
“Uniform Manner”, as utilized herein, shall mean loading
the layers of the microcolumn in a manner Such that these
layerS have a Substantially equal distribution of Support in
both a horizontal and vertical direction.
BSA=Bovine Serum Albumin

35

40

Applicants have discovered a new class of microcolumns
that allows Separation of an analyte from a Sample in the
millisecond time Scale. The microcolumns achieve Such

rapid Separation by employing a thin active layer comprising
Support particles that are capable of tolerating medium to
high flow rates and pressures during Sample injection, in
combination with a Small column volume. Applicants have
also discovered a method of loading a microcolumn in layers
to obtain a uniform, thin active layer by utilizing a plurality
of injections to load the column. This provides column
dimensions that are especially Suitable for very rapid sepa
ration of an analyte from a Sample. In addition, because of
the Small column Volumes, the microcolumn also advanta

geously employs very Small amounts of Support particles.
This is advantageous because it generally decreases the cost

45

50

55

In addition to rapid extraction of the analyte, the micro
column of the invention is typically capable of Separating
the target analyte with a high degree of Selectivity. The
microcolumn, in a particularly preferred embodiment, also
has a relatively high binding affinity for the target analyte.
The active layer, therefore, typically comprises Support
particles derivatized with any binding agent possessing the
desired Selectivity. For a separation based upon
immunoaffinity, the binding agents are antibodies raised
against the target analyte. The antibodies can be either
monoclonal or polyclonal. However, monoclonal antibodies
are generally employed in applications where a higher
degree of Selectivity is desired and polyclonals are more
typically utilized in applications where a higher degree of
binding affinity is desired. Examples of other suitable bind
ing agents for affinity chromatography include nucleic acid

ligands (e.g. aptamers), Synthetic molecular imprints, anti
body fragments (e.g. Fab fragments), antibody related mol
ecules (e.g. chimeras or F chain fragments), and recombi

Protein G Nucleosil Si-1000 (Macherey-Nagel) support or
any other Support generally known to immobilize antibod
ies. For a separation that is based on reversed phase
chromatography, a Support that contains a hydrophobic

AS utilized herein, the terms “microcolumn” or “column”

60

microcolumn of the invention. As shown in FIG. 9, the

microcolumn 1 generally has a tubular configuration with a
first end 2, a Second end 3, a passageway 4 there between,
and a retaining means at the first 5 and Second ends 6 of the
microcolumn 1. However, the microcolumn 1 may comprise
any number of different shapes, all of which are embodi
ments of the present invention. The retaining means 5, 6

column will change as the length of the column and Solvent
flow rate are varied. As illustrated by FIG. 1, only column
lengths in the Size range of about 100 microns to about 1
millimeter or less allow Separation in the millisecond time
domain when employing standard HPLC flow rates of about
0.1 to about 1.0 mL/min. Accordingly, in order to facilitate
millisecond Separation, the microcolumns of the present
invention comprise an active layer that may be less than
about 10 microns in thickness. Typically, however, the active
layer is from about 10 microns to about 1.1 millimeters in
thickness and preferably, is not less than approximately 60
microns in thickness. Applicants have found that active
layers with these dimensions, depending upon the particular
application, are typically capable of extracting an analyte in
about 1 to about 500 milliseconds. More preferably, the
analyte is separated from the Sample in less than about 200

nant proteins that act as antibody mimics. Typical Support
particles for affinity layers include antibodies adsorbed to a

of column construction.

are used interchangeably and FIG. 9 depicts a typical

thickness or width of the layer. FIG. 1, is a plot (derived by
calculation) showing how the void time for an HPLC

milliseconds.

FPLC=Fast-Protein Liquid Chromatography
HPLC=High-Performance Liquid Chromatography
DESCRIPTION OF THE PREFERRED
EMBODIMENTS

4
typically comprises a mesh or Small-pore material that acts
to hold the Support particles within the column while allow
ing fluid flow there through. The microcolumn 1 may also
contain end fittings at the first 7 and second 8 ends of the
microcolumn 1 used to connect the column to the chromato
graphic System. The microcolumn 1 comprises a thin active
layer 9 to facilitate Separation of the analyte from the Sample
in the millisecond time Scale and typically a Single inert
layer in one embodiment, to Several inert layers in additional
embodiments. FIG. 9 illustrates an embodiment with a top
inert layer 10 and a bottom inert layer 11.
The microcolumn of the present invention is particularly
Suitable for Separation of an analyte from a Sample in the
millisecond time Scale because of its relatively thin active
layer. AS utilized herein, "length' of a layer means the

65

binding agent, such as C18 Nucleosil Si-100 (Marcherey
Nagel), or any other Support generally known may be
employed. In addition, for a separation that is based upon
ion-exchange chromatography, the active Support particles
may contain anionic or cationic groups on their Surfaces.
The binding agent, once Selected, may be isolated in accor
dance with any generally known method.
The binding agent, if applicable, can be derivatized to the
Support particles by any method generally known in the art.

US 6,500,671 B2
6

S
However, the method preferably immobilizes the binding
agent to the Support particle in a manner Such that a

preSSures employed during the Separation process. Prefer
able materials for construction of the inert layer include
diol-bonded Silica, diol-bonded glass beads, agarose beads,
hydroxylated perfusion media, and glycol coated perfusion
media. The various inert layerS may be constructed from the
Same Support particles or different Support particles.
However, it is usually preferred for the Sake of convenience
in loading the microcolumn, that the inert layers comprise
the same Support particles.
The layers in the microcolumn may comprise either an
active layer alone, or an active layer and a single inert layer

relatively high percent of the binding agent is active (i.e.
binds the target analyte) after the immobilization process.

Suitable immobilization methods, for example, include the
Schiff base method and the carbonyldiimidazole method.
The Schiff base method is generally employed when immo
bilizing the binding agent through free amine groups.
However, when the binding agent comprises antibodies,
applicants have found that a more preferred approach is
immobilization through the antibodies carbohydrate region
because this generally results in an active layer with a higher
number of active binding Sites compared to when immobi
lization is performed through free amine groups. Any
method known in the art for immobilization via carbohy
drate regions may be employed.
Additionally, the Overall binding capacity of the micro
column is also an important feature, particularly when the
column is employed in methods Such as affinity
chromatography, because it impacts both the time and effi
ciency of extraction by the active layer. The binding capacity
of the column, in part, is determined by the number of active
binding siteS present in the active layer. Preferably, the
minimum number of active binding Sites in the column
comprises a ratio of active binding sites to free analyte not
less than about 1:1, and more preferably, not less than about
10:1. However, even more preferably, Support particles in
the active layer will be derivatized with the maximum
concentration of active binding agent possible So that the
column has the largest binding capacity possible.
The active layer, additionally, may comprise a number of
different Support particles. The Support particles, as detailed
above, function primarily as a Surface to immobilize the
binding agent within the active layer. The diameter of the
particle, however, is a feature that should be considered
because it impacts both the length of the active layer and the
amount of binding agent that may be immobilized in the

on top of the active layer (wherein the active layer is in
communication with the Second end retaining means) Such
15

the liquid (containing the sample) is to be applied in only a

25

35

active layer (i.e. binding capacity of the column). Preferably,

the particle size is Smaller than the length of the desired
active layer. Applicants have found that a preferred particle

40

diameter is less than about 10 times to about 20 times the

length of the active layer because particles within this size
range facilitate uniform packing of the layer. Because,
applicants have found, that a particle diameter about 10 to
about 20 times less than the active layer thickness allows for
a better opportunity for small defects in the individual
Support layers to average out and produces a more uniform
croSS-Section for this layer. In addition, the Support particles
should be able to tolerate the flow rates and pressures needed
in order to obtain the desired Sample contact time with the
active layer. The properties that affect the pressure and flow
rate that may be tolerated by the Support particles include the
diameter of the particle, the particle's shape and the porosity
of the particles. Suitable Support particles include porous or

nonporous glass, Silica and other inorganic Supports (e.g.,
alumina or Zirconia), carbohydrate-based Supports (e.g.,
beaded agarose), and polymeric Supports (e.g., poly
methacryltate or polystyrene based resins); however, one

generally skilled in the art of chromatography can Select
other appropriate Support particles.
The microcolumn will typically comprise a single inert
layer or Several inert layers, depending upon the application.
However, common features shared by all inert layers, irre
spective of their number or position within the
microcolumn, are that they generally should have no Sub
Stantial interaction with the desired analyte, and should
preferably, be mechanically stable under the flow rate and

that liquid first passes through the inert layer and then passes
through the active layer. The utilization of a single inert layer
in this manner is especially Suitable for applications where

45
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Single direction to the active layer and the column. The inert
layer in this application preferably occupies the entire length
of the microcolumn between the beginning of the first end of
the microcolumn to the beginning of the active layer So that
the entire microcolumn is filled with Support particles.
Applicants have found that having the entire microcolumn
filled with Support particles increases both the Speed and
efficiency of Separation. Additionally, the inert layer in this
application also preferably acts to distribute the injected
Sample evenly acroSS the diameter of the column before the
Sample reaches the active layer. This allows for a more
uniform application of the Sample to the relatively thin
active layer.
The layers in the microcolumn may also comprise an
active layer between a top and a bottom inert layer. AS
utilized herein, the term “top inert layer” shall mean the
layer that liquid first passes through prior to reaching the
active layer and “bottom inert layer” shall mean the layer
where liquid passes after it exits the active layer. The
microcolumn preferably comprises both a top and bottom
inert layer for applications where liquid is to be applied in
two direction to the active layer and the column. At any
given time, the flow of liquid through the column is gener
ally only in a single direction. However, for example, it is
Sometimes preferable to alternate the flow of liquid through
the column in order to help wash out any impurities that may
have built up at the top of the column during the application
of liquid. The top inert layer in this embodiment serves the
Same role as discussed above for the application employing
a single inert layer e.g. more efficient Separation. However,
applicants have found that it is preferable to include the
bottom inert layer, even in applications where fluid flow is
in only in a Single direction, because its inclusion increases
the useful life of the active layer by preventing loss of active
Support particles.
The length of the inert layer is not a critical feature and
does not affect the time needed to Separate an analyte from

the sample. In general, as Stated above, the top inert layer (if
present) is preferably the length that remains between the

beginning of the column and the beginning of the active
layer. And, the bottom inert layer, if it is present, is generally
from about 1 to about 5 times the length of the active layer.
Typically, the top inert layer is thicker than the bottom inert
layer.
The choice of a particular type of housing for the micro
column is also not a critical facet. The microcolumn
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housing, however, preferably employs components made of
materials that are Substantially inert to biological fluids and
in particular, Substantially inert to the analyte So as not to
interfere with the Separation process. Accordingly, any mate
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The slurry density (milligrams of Support particles per
milliliter of packing Solvent), or amount of Support particle

7
rial that is Substantially inert may be employed to construct
the microcolumn. Suitable materials include Stainless Steel,

polypropylene, certain plastics (such as PEEK which is a
polymer (polyetheretherketone) and is provided in the form

applied to the column per injection, will vary greatly
depending upon the desired thickness of the layer. Typically,
however, the slurry density will be from about 0.1 to about
20 milligrams of Support particles per milliliter of packing
solvent and more preferably, will be from about 1 to about
5 milligrams of Support particles per milliliter of packing

of HPLC tubing, frits and other HPLC components by
Upchurch Scientific and fused silica.
The dimensions of the microcolumn are also not a critical

feature. Any size of microcolumn may be utilized to the
extent that the total column length is preferably greater than
the length of the active layer. The total column length and
diameter also typically allow the use of sufficiently fast flow
rates and preSSures to achieve the desired contact time
between the sample and the active layer. Preferably, the

Solvent. In general, the inert layer(s) and active layer are
loaded at approximately the same slurry density. The Volume

of slurry injected per application (injection) may also be

microcolumn has an internal diameter of about 50 microns

to about 2 centimeters and a length of about 0.2 millimeters
to about 2 centimeters. In a particularly preferred
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embodiment, the microcolumn has an internal diameter of

about 0.5 to about 2.1 millimeters and a length of about 1
millimeter to about 2 centimeters.

Applicants have found that thin active layerS may be
obtained by loading the Support particles comprising the
layer into the microcolumn via a plurality of injections, as

described in more detail below (e.g. see FIG.3). The normal

method of loading a column, applying the Support particles
in one application to the column with the amount of Support
particles being in excess of that which is needed to fill the
column, is Sufficient for Standard size chromatography col
umns because due to their size, reliable packing of the
Support particles may be achieved. Applicants, however,
have found that loading the Support particles in a Single
injection, for columns with dimensions described herein,
generally does not result in an active layer capable of
reproducibly achieving separation of an analyte from a
Sample in the millisecond time Scale.
Accordingly, the layers are preferably loaded into the
column by a plurality of injections of Slurry comprising the
Support particles. The Slurry may be injected into the column
employing any apparatus generally known for injecting a
Slurry into a column, for example, a closed-loop Sample
application System with either a manual injection valve or an
automatic injection System. The Slurry, in addition to Support
particles, also preferably comprises a packing Solvent or
buffer. The packing solvent employed to load the slurry into
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the column is not a critical feature; however, the Solvent

preferably will not harm the binding agent present in the
active layer. One skilled in the art of chromatography can
readily Select both an appropriate apparatus to inject the
Slurry and appropriate packing Solvents.
Applicants have also found, as illustrated by FIG. 3,
employing a larger number of injections and leSS Support per
injection, achieves a more controlled delivery of Support
particles because Statistical variations that occur during the
delivery of Small amounts of Support particles to the column
are averaged out. This is particularly true as layer thickneSS
decreases. Uniform packing of Support particles in the
layers, especially the active layer, is preferable because it
provides more reproducible results for injected Samples by
allowing parts of the Sample that are injected at different
locations along the diameter of the column to achieve
consistent Sample contact times with the active layer.
Accordingly, the number of injections to introduce a layer
into the column is generally from about 10 to about 100.
More preferably, the number of injections to introduce a
layer is from about 30 to about 40 when the layer length is
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from about 100 to about 500 microns, and is from about 60
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to about 80 injections when the layer length is from about 60
to about 100 microns in length.
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varied as a means to control layer thickness. Typically, the
Volume of slurry injected per each application is about 50 ul
to about 300 ul. One of ordinary skill in the art can readily
determine the appropriate slurry density and Volume per
injection needed to achieve a layer having a particular
thickness when employing a specific number of injections.
For example, equation 2 Set forth in the examples Section
provides one means to determine the Slurry density to
achieve a particular layer thickneSS when loading the layer
into the column by a plurality of injections.
The desired slurry density, once Selected, is preferably
maintained throughout column injection in order to facilitate
uniform layer packing. To maintain consistent Slurry density,
the Slurry typically undergoes Shaking between injections to
ensure that the Support particles are uniformly distributed in
the slurry. It is also preferable to monitor the turbidity of the
Slurry at a wavelength of approximately 800 nm to ensure
the amount of Support particles per milliliter remains con
Stant. Furthermore, typically the slurry density is calculated
at numerous points during injection by comparison to Slur
ries of known density employing the same Support particles.
Applicants have also found, in addition to loading the
Support particles by a plurality of injections, that varying the
flow rate and pressure during column loading also serves to

provide a more stable and well-defined active layer (and
inert layer). In a particularly preferred application, the
preSSure and flow rate are increased for a short period of
time near the beginning and end of the loading of each layer.
This increased pressure and flow rate facilitates compression
of the layer and distributes the layer evenly across the
diameter of the column. In a typical column loading
procedure, for example, the flow rate of Slurry injection into
the column is between about 3 mL/min and about 5 mL/min,

with the higher flow rate occurring generally at the begin
ning and end of the loading of each layer. Additionally,
preSSure during column loading is typically maintained
between about 2000 and about 4000 psi, with a higher
preSSure preferably occurring at the beginning and end of the
loading of each layer. The particular flow rates and pressures
utilized to load each layer of the column is not a critical
feature and accordingly, may be varied significantly from the
general examples provided herein depending upon the par
ticular application.
Table 1 Sets forth a general procedure for loading a 1.0 cm
immunoaffinity microcolum employing a layer design com
prising an active layer between a top and bottom inert layer.
The procedure set forth in Table 1 is for illustrative purposes
only and shall not be construed to limit the scope of the
present invention as described in greater detail herein.
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TABLE 1.

1.
2

3

General Procedure for Preparing a Microcolumn
Assemble column fittings on the second end of
he microcolumn (and retaining means) and attach
he microcolumn to the packing apparatus;
Make two particle support slurries in the
packing solvent, one consisting of inert support
particles, and the other containing the active
support particles. For an immunoaffinity
microcolumn, the packing solvent employed may be
pH 7.0, 0.1OM potassium phosphate buffer and the
slurry of the inert support particles typically
may contain a diol-bonded material (e.g. 2 mg/mL
diol-bonded silica). The second slurry contains
he immunoaffinity support particles at a
concentration that is determined by utilizing
equation 2 or any other generally known method (as
set-forth in the examples below) and the desired
hickness of the final active layer
Begin flow of the packing solvent through the
column. This is generally done at a rate of
approximately 3 mL/min for immunoaffinity
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embodiment, the microcolumns are used in clinical Sensors

microcolumns, but is not critical. Make

approximately five injections (at 150 ul per
injection for a 1.0 cm long column) of the inert
support slurry, followed by an increase in flow
rate to approximately 5 mL/min for approximately 5
minutes

4
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Return the flow rate to approximately 3
mL/min and make the required number of injections

Return the flow rate to approximately 3
mL/min and make enough injections of the inert
support slurry to fill the remainder of the column

6

After the column bed has been filled,

Screening the interaction of large protein libraries with

Specific biological agents for use in proteomics).

bed

increase the column backpressure to the desired
level, typically about 3000 to about 4000 psi.
Allow the column to equilibrate at this pressure
for at least 30 minutes. Gradually release the
pressure. Remove the column from the packing
apparatus and place a frit (retaining means) and
end fitting onto the open end of the column. The
column is now ready for use

The microcolumn, in addition to its relatively thin active
layer, is also generally able to tolerate flow rates and
preSSures during Sample injection that are capable of achiev
ing the desired Sample contact time with the active layer. The
flow rate and pressure Selected depends not only on the
Support particles employed in its layer construction, but also
on the column diameter and upper pressure limit that can be
tolerated by the chromatographic System. In general, any
flow rate and preSSure necessary to achieve the desired
residence time and tolerated by the chromatographic System
employed is within the Scope of the present invention.
Typically, however, the microcolumns of the present inven
tion may be subjected to flow rates of between about 0.01 to
about 9.0 mL/min and pressures between about to about
6000 psi. More preferably, the pressure is between about 100
to about 1500 psi.
The microcolumns of the present invention may be
employed in any Separation System and are particularly
Suitable for applications in which short residence times or
rapid extractions are desired. Accordingly, the columns may
be used in any type of liquid chromatography including
HPLC, FPLC, and ultra high-pressure chromatography.
These categories preferably include, but are not limited to
affinity chromatography, immunoaffinity chromatography,
reversed-phase chromatography, normal phase

for the real-time monitoring of drugs, hormones or other
biological agents during Surgery or in an emergency room.
Another embodiment encompasses the use of the microcol
umns for real-time monitoring and feedback control of
biochemical reactors, Such as to generate biotechnological
products. In yet another embodiment, is encompassed the
use of the microcolumns in high-throughput Screening,

where a large number of Samples must be processed (e.g.

of the active layer (per equation 2 or any other
generally known method). After making these
injections, increase the flow rate to
approximately 5 mL/min for approximately 5 minutes
5

chromatography, adsorption chromatography, ion exchange
chromatography, chiral chromatography, capillary
electrochromatography, and Solid-phase extraction or
microextraction methods. The columns may also be
employed in gas chromatography and/or Supercritical fluid
chromatography. In a preferred embodiment, the columns
are employed in HPLC systems because these systems
facilitate flow rates and residence times that are preferable
when utilizing the microcolumns described herein.
In addition, the microcolumns of the present invention
may be utilized to Separate any analyte from a Sample.
Accordingly, in one embodiment the microcolumns may be
employed to extract an analyte from a biological Sample,
Such as the biologically active form of a drug or hormone
from a blood Sample. Additionally, the analyte may com
prise a protein, bacteria or fragment thereof, Viral particle,
toxin or environmental agent. Encompassed in another
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Additionally, the microcolumns may be employed for
Sample pretreatment or handling as part of miniaturized
Separation and analysis Systems, Such as those based upon
capillary electrophoresis or capillary electrochromatogra
phy.
The detailed description set-forth above is provided to aid
those skilled in the art in practicing the present invention.
Even So, this detailed description should not be construed to
unduly limit the present invention as modifications and
variation in the embodiments discussed herein can be made
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by those of ordinary skill in the art without departing from
the Spirit or Scope of the present inventive discovery.
All publications, patents, patent applications and other
references cited in this application are herein incorporated
by reference in their entirety as if each individual
publication, patent, patent application or other reference
were specifically and individually indicated to be incorpo
rated by reference.
Without further elaboration, it is believed that one skilled
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in the art can, using the preceding description, utilize the
present invention to its fullest extent. The following pre
ferred Specific embodiments are, therefore, to be construed
as merely illustrative, and not imitative of the remainder of
the disclosure in any way whatsoever.
EXAMPLES

The examples illustrate the ability of the microcolumns of
the present invention to extract an analyte from a Sample in
the millisecond time range under both adsorption and
diffusion-limited conditions. The examples also illustrate
that the microcolumns are able to achieve Such rapid extrac
tion when used under typical HPLC flow rates and pressure
conditions.
Materials and Methods

Reagents. The bovine hemoglobin, bovine Serum albumin
65

(BSA), fluorescein isothiocyanate (FITC)-labeled BSA,
mouse anti-BSA antibodies and mouse anti-fluorescein anti

bodies were from Sigma (St. Louis, Mo.). Sodium fluores
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to coupling, these antibodies were incubated with fluores
cein to protect their binding sites from inactivation during

cein was obtained from Matheson, Coleman and Bell

(Cincinnati, Ohio). Reagents for the bicinchoninic acid
(BCA) protein assay were purchased from Pierce (Rockford,
Ill.). HPLC-grade Nucleosil Si-1000 (7 um particle

the immobilization reaction. The immobilized antibodies

were later washed with pH 2.5, 0.10 M phosphate buffer to
release the bound fluorescein. This immunoaffinity Support
was then placed into pH 7.0, 0.10 M phosphate buffer and
used to pack a 545 um thick layer within a 2.1 mm IDX 1.0
cm column, with the remainder of the column containing
diol-bonded silica. A series of 50 ul injections of 5.4 nM

diameter, 1000 A pore size) and Nucleosil Cls Si-100 (5um

particle diameter, 100 A pore size) were obtained from
Alltech (Deerfield, Ill.). All other chemicals were reagent

grade or better and were used without further purification.
All aqueous Solutions were prepared using deionized water

fluorescein were made onto this column at flow rates of

from a Nanopure water System (Barnstead, Dubuque, Iowa).
Apparatus. All columns were packed using a CM3200

pump from Thermoseparations (Riviera Beach, Fla.) and a
modified Valco N60 six-port valve (Houston, Tex.). Prior to
packing, the Support slurries were kept in Suspension by a
Thermolyne Rotomix 50800 mixer (Dubuque, Iowa).
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Samples for the manual BCA protein assay and Slurry
turbidity measurements were analyzed using Shimadzu

UV160U absorbance spectrophotometer (Kyoto, Japan).

Chromatographic Studies were conducted using an LDC
CM3200 pump, a model 713 autosampler from
Thermoseparations, and a Rheodyne 7126 Six-port injection

valve (Cotati, Calif.). An LDC SM3100X absorbance detec

tor was used to monitor hemoglobin during its reversed
phase extraction. The extraction of fluorescein and elution of

FITC-labeled BSA was examined with a Shimadzu RF-535
fluorescence detector.

25

Microcolumn Preparation. The diol-bonded, aldehyde
activated, and immobilized protein Supports were prepared
from Nucleosil Si-1000, as described previously. The micro
columns were packed using a calibrated injection loop and
Support slurry of known concentration. The concentration of
each Slurry was determined in advance by turbidity mea

same buffer and the amount of non-retained labeled BSA

Surements at 800 nm verSuS Standard Solutions that con

tained known concentrations of the Support and packing
Solvent.
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The permeability Studies were performed in triplicate
using columns packed with diol-bonded Silica of various
pore sizes. The back pressure of these columns was mea
Sured as a function of flow rate between 0.0 and 3.0 mL/min.

At each new flow rate the system was allowed to stabilize
before the back preSSure was measured.
Packing reproducibility was examined by optical microS
copy and by performing protein assays on microcolumns
containing immobilized hemoglobin Silica. After packing

40

these columns, their contents were removed and examined
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under a microScope or placed into a fixed Volume of pH 7.0,
0.10 M phosphate buffer. The hemoglobin content of this
latter Suspension was determined by a BCA protein assay.
After allowing the color of this assay to develop for 60 min,
the Support was removed from the reaction Slurry by using
a 0.45 micron syringe filter and the absorbance of the filtrate
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bonded sillica was used to fill the remainder of the column

housing. A Series of 10 till injections of a 2 tug/mL hemo
globin solution were made onto this column in pH 7.0, 0.10
M phosphate buffer at effective residence times ranging
from 1-600 ms. The amount of non-retained hemoglobin
was measured at 428 nm and was compared to the Signal
obtained when no C Support was present in the chromato
graphic System.
The immunoaffinity support for the adsorption-limited
Studies was prepared by coupling anti-fluorescein antibodies
to diol-bonded silica through the Schiff base method. Prior

was monitored through its fluorescence at excitation and
emission wavelengths of 488 and 520 nm. The retained BSA
and labeled BSA were later eluted with pH 2.5, 0.10 M
phosphate buffer. The column was then re-equilibrated with
pH 7.4, 0.10 M phosphate buffer before the next sample
injection.
Example 1
Preparation of Microcolumns
One goal of this work was to decrease the residence times
that could be obtained with HPLC columns while still

was measured at 562 nm.

Chromatographic Studies. All Studies were performed at
room temperature. The reversed-phase extraction of hemo
globin was Studied using a 2.1 mm IDX 1.0 cm column which
contained a 1.1 mm layer of Cs. Nucleosil Si-100; diol

0.4-1.1 mL/min using pH 7.0, 0.10 M phosphate buffer as
the application Solvent. The amount of non-retained fluo
rescein was monitored by using on-line fluorescence detec
tion with excitation and emission wavelengths of 488 and
520 nm, respectively. Between each injection, the column
was washed with pH 2.5, 0.10 Mphosphate buffer, followed
by re-equilibration with the pH 7.0 application buffer. The
relative amount of extracted fluorescein was determined by
comparing the non-retained peak areas of the anti
fluorescein column to peak areas measured for the same
Samples when applied at identical flow rates to a column that
contained only diol-bonded Silica.
The immunoaffinity Support for the chromatographic
competitive binding immunoassay was prepared by adsorb
ing anti-BSA antibodies to a 2.1 mm IDX 1.0 cm column that
contained a 1.1 mm thick layer of an immobilized protein G
Support. Antibodies were placed onto this column by making
two 50 lull injections of anti-BSA antiserum at a flow rate of
0.05 mL/min in pH 7.4, 0.10 M phosphate buffer. Samples
containing FITC-labeled BSA and BSA were injected in the
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allowing the use of these columns at Standard flow rates. It
is difficult to pack an ordinary chromatographic column with
a length of less then a few millimeters, So a Sandwich-based
method was used instead. This was accomplished by
employing a conventional HPLC pump and injection valve
to apply Slurry of one or more types of Supports to a column.
Table 1 shows the procedure used to make a typical column
for this study. For convenience in handling and for protec
tion of the Stationary phase layer, the column was first filled
partially with a biologically-inert material, Such as diol
bonded Silica. After this Support had been placed into the
column, the flow rate of the packing Solvent was increased
to ensure that this material was present in an even layer. A
layer of the desired active Support was next placed into the
column in a similar manner to give a Sandwich microcol
umn. The length of this layer was determined by the
concentration and Volume of the injected Support slurry and
the number of injections that were made of this slurry. The
remainder of the column was then filled with diol bonded

Silica or Some other inert Support to remove any dead Space
at the head of the column.

A picture of a typical microcolumn that was prepared for

this study is shown in FIG. 2. The effective length (L) and

65

volume (V) occupied by the stationary phase layer within

Such a column was adjusted by using the following
equations,

US 6,500,671 B2
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were obtained by this technique for a 620 um Support layer.
AS can be seen from this plot, an increase in the number of

13
Le=(Nin Vit)/(pro)

(2)

Slurry injections (with a corresponding decrease in slurry
concentration) resulted in a significant improvement in the

Where C is the concentration of the support in the injected

precision of the packing method. In this example a variation
of less than 5% in support delivery was obtained when using
32 injections of a 0.3 mg/mL slurry. For longer
microcolumns, an even better precision was obtained under
comparable conditions; however, work with Smaller column
lengths required a greater number of injections to obtain

slurry, V is the volume of this slurry which was applied
with each injection, N, is the total number of slurry

injections that were made of the given Support, p. is the
packing density of the Support within the column, and r is the
internal radius of the column. An experimentally-measured

Similar results.

packing density of 0.64 g/cm was used for the silica

employed in this work and the calibrated injection volume
was 152 till. A total of 32 or 64 injections for a particular
Support was usually employed, as will be discussed later.
The length of the Support layer was varied by changing the
density of its injected slurry. In the initial Stages of this work,
the final lengths of the Support layers in the microcolumns
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were determined by using a colored Support (as shown in
FIG. 2) and optical microscopy to measure the thickness of
this layer. In each case, the actual thicknesses of the Sta
tionary phase layers were found to agree within experimen
tal error to the lengths that were estimated by using Eqn. 2.
The total length of all columns used in this work was 1.0
cm, which included both the Stationary phase-coated Support
and all inert materials. However, the thickness of the Sta

tionary phase layer (referred to here as the microcolumn
“length”) ranged from 1.1 mm to 60 um. Since these

25

The reproducibility of microcolumn packing was tested.
One way this was done was by comparing the total protein
content of Several columns that had been packed with Small
layers of an immobilized hemoglobin support. When two
injections of a 4.8 mg/mL slurry were made of this material,
this delivered a 620 um thick layer with a precision of

umns with 7 um diameter HPLC-grade silica that had
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Sources included 1) potential changes in the slurry density
between injections and 2) possible variations in the Slurry

AP=(uent)/B,
40
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Volume that was applied with each injection onto the col

(3)

the columns interstitial porosity, m is the mobile phase
Viscosity, L is the total column length, AP is the change in
preSSure acroSS the column, and B is the Specific perme
ability of the Support within the column.
According to Eqn. 3, the overall permeability of the

column (B) can be determined from the slope of plots like
those in FIG. 4 by converting from flow rate to linear
Velocity and using the known or measured values of e, m

and L. The permeabilities that were measured for the sand
wich microcolumns are given in Table 2 for Several porous
Silica Supports. Based on these values, the maximum uSable
flow rates for microcolumns packed with these materials
were calculated to range from 12 to 17 mL/min at a back
pressure of 3000 psi; in practice, an upper limit of 9-10
mL/min was actually observed because of Some non
linearity that occurred in plots of back pressure verSuS flow

rate when working at high flow rates (see upper plot in FIG.
4). However, work at flow rates below this range was more

than adequate for this Study Since a typical 500 um longx2.1
mm ID microcolumn allowed Sample residence times of

U.

To ensure that the Slurry density remained constant over
time, this density was routinely monitored by turbidity
measurements and maintained by Vigorous mixing of the
Slurry between injections. This resulted in Slurry densities
that showed less than a few percent variation over even a
large Series of injections. An approach was also developed
for minimizing the effects of variations in the injection
Volume; this was done by using a large number of injections
of dilute slurry Suspensions to average out Such effects and
reduce their overall impact. FIG. 3 shows some results that

nominal pore sizes of 300-4000 A. These supports were
chosen because they are commonly used for proteins and
other biological molecules in HPLC. For each type of
Support, a plot was made of back pressure versus flow rate,
as shown in FIG. 4. This type of plot was then analyzed by
using the Darcy equation,

where U is the linear velocity of the mobile phase, e is

approximately 20% (+1 RSD). This reproducibility was

much worse than the precision of only a few percent that was
observed for the protein assay itself, thus indicating that this
variability was mainly due to the packing method. Several
possible Sources of this variability were considered to
improve the reproducibility of the packing procedure. These

Another Series of Studies were performed to determine the

employed with the Sandwich microcolumns. This required
that some information be obtained on the permeability of
these columns. This was done by packing Several microcol

time and Solvent conditions that were considered in this

Evaluation of Sandwich Microcolumns

in the longer microcolumns (effective lengths, 60 um-1.1
mm) that were used in the remainder of this study.

flow rates and column residence times that could be

columns were packed with 5-7 um Silica particles, these
microcolumns had effective lengths that were equal to only
9-157 particle diameters. Work with Such small columns
was possible because the Separations that were to be per
formed with them were essentially irreversible under the

Study. This gave rise to extractions and assays, which
generally involved the use of only Single contacts between
the retained molecules and the Stationary phase. Several
Specific examples of Such applications are provided below.
Example 2

Microcolumns containing a colored Support, like the
hemoglobin silica shown in FIG. 2, were inspected by
optical microScopy for their packing uniformity. It was
found that columns containing Support layers of 60 um in
length or greater gave level, well-defined boundaries. But
attempts to pack even Smaller columns gave rise to Some
edging effects in which the Support layers were no longer
packed evenly acroSS the diameter of the column. In this
case, the walls of the column contained a slightly larger layer
of the colored Support than the Section in the center of the
column. It is believed that this is due to the presence of Some
flow heterogeneity within the column during the packing
procedure. Such an effect was not noticeable or significant

40-80 ms to be obtained at 1-2 mL/min. As will be shown

later, residence times as low as even 1–2 mS could be
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obtained by using shorter columns and/or higher flow rates
for Sample application.
Example 3
Extraction by Sandwich Microcolumns Under
Adsorption-limited Conditions
The next series of experiments considered the behavior of
Sandwich microcolumns in extractions performed in Systems

US 6,500,671 B2
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with either “diffusion-limited' or “adsorption-limited”
kinetics for analyte retention. This was based on a model in
which analyte interaction with the Stationary phase was

antibodies in the anti-fluorescein microcolumns which was

roughly 2000 to 3000-times greater than the moles of
fluorescein that were injected. As can be seen from FIG. 6,
this level was more then sufficient to allow quantitative

viewed as consisting of two distinct steps (see FIG. 5): 1)
movement of the analyte to the Surface of the Stationary
phase by diffusion, and 2) adsorption or interaction of the

extractions of fluorescein to be achieved in the Sub-Second
time domain.

analyte with the stationary phase. The term “diffusion
limited kinetics” is used here to refer to a system in which
the overall rate of analyte binding to the Stationary phase is
dictated by how fast the analyte can get to the Stationary
phase from the flow mobile phase. For the model shown in
FIG. 5, this occurs when the rate constant k is much larger

Example 4
Extraction by Sandwich Microcolumns Under
Diffusion-limited Conditions

than k or k . The opposite situation (adsorption-limited
kinetics) occurs when k and k are much larger thanka. In

this situation, the analyte gets to the Stationary phase at a rate
that is much faster than analyte-stationary phase binding,
thus making this Second process the rate-limiting Step in
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retention.

The first case, which was examined, was that of a System
with adsorption-limited kinetics. This was accomplished by

injecting a Small analyte (fluorescein) onto a column that
contained anti-fluorescein antibodies attached to HPLC

grade Silica. Previous Studies have shown that antibody
antigen Systems. Such as this tend to display adsorption
limited kinetics when the antibody is part of an HPLC
column. Each fluorescein Sample was first injected in trip
licate at various flow rates onto an inert column containing
only diol-bonded silica, to which fluorescein does not bind,
in order to determine the total expected peak area. The same
Sample was then applied to a Sandwich microcolumn of the
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Samples on an inert control column that contained only
The data that were obtained with this system are illus
trated in FIG. 7. It was found that up until the point of

column Saturation (which occurred after about twenty-four
100 uL injections of 2 mg/mL hemoglobin) greater than 95%

Same overall size as the inert control column, but which now

of the injected hemoglobin was extracted at residence times
as short as 4 ms. This was followed by a fairly sharp
35

The results of this experiment are summarized in FIG. 6.
It was found that greater than 95% extraction of fluorescein
could be obtained in as little as 100-120 ms with Sandwich
microcolumns. Previous studies with antibodies attached to

low-performance agarose Supports have reported greater
than 95% binding in roughly 100 s or 40% extraction of
analytes in 2 s, while antibodies attached to HPLC Supports
have been shown to give quantitative extraction in as little
as 6 s. However, this present study is the first report in which
quantitative binding with immunoaffinity Supports has been
noted in the millisecond time range. Similar Studies were
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conducted with Sandwich microcolumns and antibodies

directed against other analytes. For instance, the analytes
L-thyroxine and warfarin have also been found to give
quantitative extraction in only 60-150 ms by such columns.
When attempting this type of rapid extraction, it is nec
essary to consider the amount of Stationary phase that is
actually present in the column for analyte retention. Increas
ing the amount of Stationary phase per unit volume not only
helps avoid column overloading, but in an adsorption
limited System this also helps to speed the net rate of
retention by increasing the probability that an analyte will
encounter an unoccupied binding site as it approaches the
Stationary phase. Typically, immunoaffinity extractions use a
large excess of antibodies to help avoid these problems. But
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decrease in extraction efficiency at shorter times (i.e., 1-2
ms). This extraction rate was much faster than what was

observed in FIG. 6 for the fluorescein/anti-fluorescein sys
tem. One reason for this is that the fluorescein System had
adsorption-limited kinetics in which retention was limited
by the rate at which the analyte could reach unoccupied
antibody Sites with a proper orientation for binding. In
contrast to this, the binding of hemoglobin to Cs. Silica is a
much faster, but leSS Specific, diffusion-limited process that
involves a greater number of potential binding regions and
in which many more collisions of hemoglobin with the
Stationary phase result in analyte retention.
Example 5
Use of Sandwich Microcolumns in

Chromatographic Immunoassays
The last series of studies considered the use of Sandwich
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this can be more difficult to attain in microcolumns, where

the Space available for the Stationary phase is minimal. To
address this, the anti-fluorescein antibodies used in this

study were immobilized under conditions which have pre
viously been shown to maximize the density of antibodies
on HPLC-grade silica Supports. This provided an amount of

microcolumn and those that were obtained for the same
diol-bonded silica.

contained a well-defined layer of anti-fluorescein antibodies.
The degree of extraction was then determined by comparing
the Size of the non-retained peaks for fluorescein on the
microcolumn to those measured at the same flow rates on the
control column.

The Second type of kinetic case considered was the use of
Sandwich microcolumns to extract analytes under diffusion
limited conditions. An example of Such a System is the
retention of a protein like hemoglobin by a reversed phase
Support. This was Studied by packing a Sandwich microcol
umn that contained a 1.1 mm layer of Cs. Silica between
layers of diol-bonded silica. The degree of extraction of
hemoglobin Samples was estimated by making a continuous
Series of protein injections, with no elution Step in between,
until the column was saturated with hemoglobin. All of the
peak areas were then compared to those for peaks which
were generated after column Saturation. A similar compari
Son was made between the peaks measured on the Cs
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microcolumns in a chromatographic immunoassay. This
type of assay uses immobilized antibodies or antigens as part
of a chromatographic System for the fast and Selective
determination of analytes. The most common format for
Such an assay is the competitive binding mode. In this
format, analyte in the Sample is incubated with a fixed
amount of a labeled analyte analog and is applied to a
column that contains a limited amount of antibodies that can

bind to both of these species. This is most often done by
Simultaneously injecting the analyte and its labeled analog
onto the column, but Sequential injection can also be
employed. The antibody-bound fraction of both compounds
is then Separated from the fraction that remains free in
solution. From this, the amount of labeled analyte that was
in the free or bound fraction can be determined, thus
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providing an indirect measure of how much analyte was in
the original Sample.

apparent to those of ordinary skill in the art in light of the
foregoing examples and detailed description. Accordingly,
this invention is intended to embrace all Such alternatives,

Sandwich microcolumns are attractive for use in Such

modifications, and variations that fall within the Spirit and
Scope of the following claims.

assays because they provide a convenient way of placing a
Small amount of antibodies into a column while still allow

What is claimed is:

ing work to be performed at flow rates and column residence
times that allow a competition to be established between the
analyte and its labeled analog. In addition, the use of

1. A method of loading a microcolumn comprising an
active layer and an inert layer, the active layer being capable
of Separating an analyte from a Sample, the method com
prising:

microcolumns will minimize the Surface area to which the

analyte and label are exposed. This should help reduce
non-specific binding, which is often a limiting factor in
determining the lower limit of detection that can be obtained
in immunoassayS.
A chromatographic competitive binding immunoassay
with microcolumns was developed by using the competition

(a) introducing the active layer into the microcolumn by
a plurality of injections Such that the active layer is
capable of Separating the analyte from the Sample

within the millisecond time domain; and
15

2. The method of claim 1 wherein the active layer is
introduced into the microcolumn as slurry, the Slurry com
prising particles that form the active layer and a packing

of labeled and non-labeled BSA as a model. Anti-BSA

antibodies were first adsorbed to a protein G microcolumn to
form an immunoaffinity Stationary phase. Various mixtures

Solvent.

of FITC-labeled BSA and non-labeled BSA were then

injected onto this column, with the non-retained labeled
BSA being monitored by an on-line fluorescence detector.
Some typical chromatograms obtained by this method are
shown in FIG. 8. The sample on the left contained only a
Solution of the labeled BSA, while the second and third

Samples to the right contained the same amount of labeled
BSA plus either a 10-or 50-fold excess of normal BSA.

25

5. The method of claim 2 wherein the pressure during
Slurry injection is varied Such that the pressure is increased
at the beginning and end of the introduction of each layer

Sample containing only this labeled compound. Injection of
this label plus a 10-fold excess of non-labeled BSA yielded
a 15% decrease in the binding of labeled BSA, and injection
of the labeled BSA plus a 50-fold excess of non-labeled BSA

loaded into the microcolumn.

6. The method of claim 1 wherein the inert layer is
introduced into the microcolumn as slurry, the slurry com
prising particles that form the inert layer and a packing

gave a 65% decrease in binding (see FIG. 8). It is this inverse
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Solvent.

7. The method of claim 6 wherein the particles are
Selected from the group of materials consisting of diol
bonded Silica, diol-bonded glass beads, agarose beads,
hydroxylated perfusion media, and glycol coated perfusion
40

media.

8. The method of claim 6 wherein the particles comprise
diol-bonded silica.
45

9. The method of claim 6 wherein the particles of the inert
layer, when the column is in use do not Substantially interact
with the analyte.
10. The method of claim 1 wherein the number of

injections to introduce the active layer into the microcolumn
is from about 30 to about 40 when the layer length is from
50

about 100 to about 500 microns.
11. The method of claim 1 wherein the number of

injections to introduce the active layer into the microcolumn
is from about 60 to about 80 when the layer length is from
about 60 to about 100 microns.
55

12. The method of claim 1 wherein the active layer is
introduced into the microcolumn as a Slurry, the slurry
comprising particles that form the active layer and a packing
Solvent.

be viewed in terms of the claims that follow and their

equivalents. While Some of the examples and descriptions
above include Some conclusions about the way the invention
may function, the inventor does not intend to be bound by
those conclusions and functions, but puts them forth only as
possible explanations.
It is to be further understood that the specific embodi
ments of the present invention as Set forth are not intended
as being exhaustive or limiting of the invention, and that
many alternatives, modifications, and variations will be

3. The method of claim 2 wherein the particles are
Selected from the group of materials consisting of porous
glass, nonporous glass, Silica, inorganic Supports, carbohy
drate based Supports, and polymeric Supports.
4. The method of claim 2 wherein the flow rate of slurry
during injection is varied Such that the flow rate is increased
at the beginning and end of the introduction of each layer
loaded into the microcolumn.

An 80% extraction of labeled BSA was achieved in the

relationship between binding of the labeled analog and the
concentration of the unlabeled analyte, which can be used
for analyte measurements. For each injected Solution, the
amount of time the Sample was in contact with the immu
noaffinity Support was approximately 180 ms. However, a
signal was not observed until about 5-25s after injection
due to the additional time that was required for the Sample
to pass out of the injection loop and through the column,
connecting tubing and detector. These results clearly indi
cate that a Sandwich microcolumn can be used to perform
competitive binding immunoassays on very short time
scales. This approach is not limited to BSA, but could also
be employed with any other compounds for which antibod
ies and an appropriately labeled analog are available.
In light of the detailed description of the invention and the
examples presented above, it can be appreciated tha the
Several aspects of the invention are achieved.
It is to be understood that the present invention has been
described in detail by way of illustration and example in
order to acquaint otherS Skilled in the art with the invention,
its principles, and its practical application. Particular for
mulations and processes of the present invention are not
limited to the descriptions of the Specific embodiments
presented, but rather the descriptions and examples should

(b) introducing the inert layer.
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13. The method of claim 12 wherein the slurry density is
from about 0.1 to about 20 milligrams of particles per
milliliter of packing Solvent.
14. The method of claim 12 wherein the slurry density is
from about 1 to about 5 milligrams of particles per milliliter
of packing Solvent.
15. The method of claim 14 wherein a consistent slurry
density is maintained during injection by mixing the slurry
between injections and measuring the turbidity of the slurry
at a wavelength of approximately 800 nm.
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16. The method of claim 1 wherein the number of
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19. The method of claim 1 wherein the active layer is not
less than about 60 microns in length.
is from about 10 to about 100.
20. The method of claim 1 wherein the inert layer is at
17. The method of claim 1 wherein the particles are
5 least about 1 to about 5 times the length of the active layer.
introduced into the column in a uniform manner.
18. The method of claim 1 wherein the active layer is from
about 10 microns to about 1.1 millimeters in length.
injections to introduce the active layer into the microcolumn
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